Article
Clinical Risk Score to Predict Pathogenic Genotypes in Patients With Dilated Cardiomyopathy.
Journal of the American College of Cardiology - 20 Sept 2022
Escobar-Lopez Luis, Ochoa Juan Pablo, Royuela Ana, Verdonschot Job A J, Dal Ferro Matteo, Espinosa Maria Angeles, Sabater-Molina Maria, Gallego-Delgado Maria, Larrañaga-Moreira Jose M, Garcia-Pinilla Jose M, Basurte-Elorz Maria Teresa, Rodríguez-Palomares José F, Climent Vicente, Bermudez-Jimenez Francisco J, Mogollón-Jiménez María Victoria, Lopez Javier, Peña-Peña Maria Luisa, Garcia-Alvarez Ana, López-Abel Bernardo, Ripoll-Vera Tomas, Palomino-Doza Julian, Bayes-Genis Antoni, Brugada Ramon, Idiazabal Uxua, Mirelis Jesus G, Dominguez Fernando, Henkens Michiel T H M, Krapels Ingrid P C, Brunner Han G, Paldino Alessia, Zaffalon Denise, Mestroni Luisa, Sinagra Gianfranco, Heymans Stephane R B, Merlo Marco, Garcia-Pavia Pablo
Abstract excerpt
BACKGROUND: Although genotyping allows family screening and influences risk-stratification in patients with nonischemic dilated cardiomyopathy (DCM) or isolated left ventricular systolic dysfunction (LVSD), its result is negative in a significant number of patients, limiting its widespread adoption. OBJECTIVES: This study sought to develop and externally validate a score that predicts the probability for a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.